Skip to the page

Data / Form D filings / BioMedInnovations LLC

BioMedInnovations LLC: Form D filing

BioMedInnovations LLC, a biotechnology company in Denver, NC, filed a Form D with the SEC in 2024. The latest, on April 10, 2024, reports $100,000 sold of a $9 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
771 CROSSPOINT DRIVE, Denver, NC, 28037
Phone
(704) 413-7694
Industry
Biotechnology
Entity type
Limited Liability Company
Incorporated in
North Carolina
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2019097

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 10, 2024New notice$9,000,000$100,000$8,900,0001Mar 17, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Elizabeth FlanaryDirector
George BarrDirector
Robert NeusnerExecutive Officer
Carrie DiMarzioExecutive Officer, Director
David GerberExecutive Officer

Other biotechnology companies in North Carolina that filed recently

Every Form D from the week of Apr 8, 2024 · All recent filings in North Carolina · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what BioMedInnovations LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.